Aussie Oncologists Say Trial Trend Makes Treatments Costlier
This article was originally published in PharmAsia News
Executive Summary
Australian oncologists are calling for independent research of cancer drugs to guard against overuse of expensive ones and those more toxic. The physicians wrote in a professional journal that clinical trials have shifted to testing how long drugs could be tolerated and away from using them until maximum response is determined and then halting their use to avoid toxicity. Their article in The Medical Journal of Australia said that shift toward longer use is not supported by survival or quality-of-life data, making treatment potentially much costlier. (Click here for more
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.